Starting Dose for Vyvanse
For stimulant-naïve patients, start lisdexamfetamine (Vyvanse) at 20-30 mg once daily in the morning for both children (≥6 years) and adults.
Dosing Algorithm
Initial Dosing
- Starting dose: 20-30 mg once daily 1
- Administer in the morning
- Can be taken with or without food (though food delays peak effect by ~1 hour) 2
Titration Schedule
- Increase by 10 mg weekly until optimal response is achieved 1
- Maximum dose: 70 mg daily 1, 2
- Continue weekly increases based on symptom control and tolerability
Important Context from General Amphetamine Guidelines
While the provided guidelines [3-3-3] recommend starting immediate-release dextroamphetamine/amphetamine at 2.5 mg for children and 5 mg for adults, these recommendations apply to immediate-release formulations, not to Vyvanse. Lisdexamfetamine is a prodrug with unique pharmacokinetics—it requires enzymatic conversion in red blood cells to active dextroamphetamine, resulting in a gradual, extended release profile 2.
The 20-30 mg starting dose for Vyvanse reflects this prodrug design and once-daily extended-release formulation, which provides approximately 12-14 hours of symptom control 4, 5, 6.
Pre-Treatment Requirements
Before initiating Vyvanse:
- Obtain baseline vital signs: blood pressure, pulse, height, and weight [3-3]
- Cardiovascular screening: Document any personal or family history of cardiac disease, sudden death, or arrhythmias 7
- Document prior treatments: Previous medications, psychosocial interventions, and their responses [3-3]
Monitoring During Titration
- Weekly contact (office visit or phone) during dose adjustments 3
- Assess ADHD symptoms using rating scales from parents/teachers (children) or self-report (adults) 3
- Monitor for adverse effects: decreased appetite, insomnia, irritability, headache 5, 6, 8
- Check vital signs at each dose increase
Special Populations
Preschool Children (Ages 4-5)
- Start at 5 mg daily if treatment is necessary 8
- This age group shows smaller effect sizes and requires careful risk-benefit assessment
- Only consider if moderate-to-severe dysfunction persists after behavioral interventions 7
Adults
- Same starting dose as older children: 20-30 mg once daily 1
- May require full 70 mg dose to cover longer working day 3
Common Pitfalls to Avoid
- Don't start too low: Unlike immediate-release amphetamines (2.5-5 mg), Vyvanse's prodrug formulation requires 20-30 mg to achieve therapeutic effect
- Don't titrate too quickly: Weekly increases allow proper assessment of response and tolerability
- Don't confuse with immediate-release guidelines: The older guidelines [3-3] reference immediate-release formulations with different pharmacokinetics
- Don't skip cardiovascular screening: Stimulants carry cardiovascular risks requiring baseline assessment [3-3,7]
Safety Profile
Most common adverse effects (>10% incidence):
Expected cardiovascular changes:
- Modest increases in pulse (mean +2.7 bpm) and blood pressure (systolic +1.0 mmHg, diastolic +1.7 mmHg) 8
- Monitor quarterly in adults, annually in children [3-3]